Zyban is an antidepressant and smoking cessation aid
Zyban is an antidepressant and smoking cessation aid. Recent clinical studies have suggested that the atypical antidepressant, zyban (Wellbutrin), may stimulate sexual desire in women. It is possible that zyban treatment enhanced female attractiveness. Males paired with zyban-treated females successfully achieved a greater number of ejaculations and demonstrated significantly shortened post-ejaculatory intervals.
Major depressive disorder (MDD) is a common psychiatric condition, with 6.6% of the adult population in the United States experiencing a major depressive episode during any given year. Understanding the PK profile and formulations of zyban can help optimize clinical use. Zyban is metabolized extensively, resulting in 3 active metabolites.
Twenty percent of patients with cardiovascular disease smoke, and smoking cessation results in a dramatic decline in the relative risk of future cardiovascular events. Zyban was developed for the treatment of depression, but subsequently was found to be effective for smoking cessation. The higher rates of spontaneous abortions are similar to other studies examining the safety of antidepressants during pregnancy.
Several arguments can be made in support of the search for non-nicotine therapies to improve smoking cessation success. Zyban SR was shown to be effective and well tolerated in decreasing the risk for relapse of depression for up to 44 weeks. Cigarette smoking is the leading preventable cause of death in the United States and a major risk factor for cardiovascular disease (CVD). Zyban reduces the subjective effects and cue-induced craving for methamphetamine in humans. Delayed seizure onset suggests a minimum observation period of 24 hours after zyban XL overdose. Hypersensitivity reactions to zyban are fairly common and include rare cases of serum sickness-like reaction.
Modest mean weight losses that increased with increasing baseline body weight were observed with long-term zyban SR treatment. Incomplete symptom remission and sexual side effects are common problems for which zyban often is added to treatment with selective serotonin and serotonin–norepinephrine reuptake inhibitors (SSRIs and SNRIs) for patients with major depressive disorder (MDD). Although patients experiencing agitation or tremors may be at greater risk, seizures can occur without preceding central nervous system toxicity. While a great progress is being made, there is clearly much work left to be done. Therefore, developing effective antidepressant treatments with pro-dopaminergic properties which also possess a relatively wide safety margin may further improve the standard of care for depression.
The escalating problem of obesity has initiated an unprecedented search for novel anti-obesity drugs. Future strategies are likely to combine drugs with complementary central and peripheral mechanisms of action to enhance therapeutic benefit. The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study addressed many clinically relevant issues on treatment of depressed outpatients.
Zyban Sr without prescription is a medicine that is used to help you stop smoking. The following article was published by a Pharmacy Without Prescription.
